C. diff. Survivors Join International Topic Experts to Discuss Global Problems Around Leading Healthcare-acquired Infection Clostridium difficile

0
192

ATLANTA, Ga., June 20, 2016 (SEND2PRESS NEWSWIRE) — C Diff Foundation’s 4th Annual International Raising C.diff. Awareness Conference and Health EXPO will be hosted in Atlanta, Ga. on September 20, 2016. A panel of C. diff. survivors will join world-renowned experts delivering presentations on health care topics pertaining to the most common pathogen identified, a leading healthcare-associated infection (HAI) in U.S. hospitals alone: Clostridium difficile (C. diff.).

C.diff. Awareness Conference
Nearly half a million Americans suffer from Clostridium difficile (C. diff.) infections in a single year according to a study released February 2015 by the Centers for Disease Control and Prevention (CDC). About 15,000 deaths were estimated to be directly attributable to C. diff. infections.

Previous studies indicate that C. diff. has become the most common microbial cause of healthcare-associated infections found in U.S. hospitals driving up costs to $4.8 billion each year.

Bringing medical professional guest speakers together, such as Dr. Clifford McDonald, MD from the Centers of Disease Control and Prevention (CDC), one of the leading government healthcare organizations in the U.S., and internationally recognized experts on healthcare-associated infections and the prevention of antimicrobial resistance – provides an educational opportunity for healthcare professionals and those sharing common interests. Presentations will be focused on, but not limited to Clostridium difficile (C. diff.) Prevention, Treatments, Research, Clinical trials, Microbiome research, Infection Prevention, Environmental Safety, Fecal Microbiota Restoration, Antibiotic Stewardship.

The “International Raising C.diff. Awareness” Conference and Health EXPO will commence on September 20, 2016, 7:30 a.m. – 5 p.m. Eastern Time at the DoubleTree by Hilton Hotel – Atlanta Airport, 3400 Norman Berry Drive, Atlanta, GA 30344 (Hotel Phone: 1-404-763-1600).

SPONSORS: Platinum Sponsors include: Summit Therapeutics, Clorox Healthcare, Seres Therapeutics, Rebiotix, and TOMI Environmental Solutions SteraMist. Gold Sponsors include: Synthetic Biologics, XBiotech, CoreShield, Nestle Health Science, Roche, DaVolterra, and Xenex Germ-Zapping Robots. This conference is supported through an educational grant from Sanofi Pasteur US.

Additional information and registration: https://cdifffoundation.org/2016events/

“None of us can do this alone. All of us can do this together,” says Nancy C. Caralla.

About the C Diff Foundation:
The C Diff Foundation, a 501(c)(3) non-profit, was founded in 2012 by Nancy C. Caralla, a Nurse who was diagnosed and treated for Clostridium difficile (C. diff.) infections not once but twice. Through her own journey and witnessing the loss of her father to C. difficile infection involvement, Nancy recognized the need for greater awareness through education, about research being conducted by the government, industry, and academia and better advocacy on behalf of patients, healthcare professionals, and researchers worldwide working to address the public health threat posed by this devastating, life-threatening infection.

About The C Diff Foundation Foundress, Executive Director:
Nancy C Caralla, hosts “C. diff. Spores and More” Global Broadcasting Network, and shares in a team focus on educating, and advocating for C. diff. infection prevention, treatments, and environmental safety; and more, worldwide.

More information: http://www.cdifffoundation.org/

Editorial note on usage:
– C. diff. for abbreviation of Clostridium difficile.
– C Diff Foundation when referring to the organization.
– Event: “International Raising C.diff. Awareness Conference and Health EXPO.”

News Source: C Diff Foundation

To view the original post, visit: https://www.send2press.com/wire/c-diff-survivors-join-international-topic-experts-to-discuss-global-problems-around-leading-healthcare-acquired-infection-clostridium-difficile/.

This press release was issued by Send2Press® Newswire on behalf of the news source, who is solely responsible for its accuracy. www.send2press.com.

NO COMMENTS